Abstract

Drug delivery systems (DDSs) limited to a single function or single-drug loading are struggling to meet the requirements of clinical medical applications. It is of great significance to fabricate DDSs with multiple functions such as magnetic targeting or fluorescent labeling, as well as with multiple-drug loading for enhancing drug efficacy and accelerating actions. In this study, inspired by the dual-chamber structure of rapeseed pods, biomimetic magnetic–luminescent bifunctional drug delivery carriers (DDCs) of 1.9 ± 0.3 μm diameter and 19.6 ± 4.4 μm length for dual drug release were fabricated via double-needle electrospraying. Morphological images showed that the rapeseed pod-like DDCs had a rod-like morphology and Janus dual-chamber structure. Magnetic nanoparticles and luminescent materials were elaborately designed to be dispersed in two different chambers to endow the DDCs with excellent magnetic and luminescent properties. Synchronously, the Janus structure of DDCs promoted the luminescent intensity by at least threefold compared to single-chamber DDCs. The results of the hemolysis experiment and cytotoxicity assay suggested the great blood and cell compatibilities of DDCs. Further inspired by the core–shell structure of rapeseeds containing oil wrapped in rapeseed pods, DDCs were fabricated to carry benzimidazole molecules and doxorubicin@chitosan nanoparticles in different chambers, realizing the sequential release of benzimidazole within 12 h and of doxorubicin from day 3 to day 18. These rapeseed pod-like DDSs with excellent magnetic and luminescent properties and sequential release of dual drugs have potential for biomedical applications such as targeted drug delivery, bioimaging, and sustained treatment of diseases.

Highlights

  • Introductionmagnetic nanoparticles (MNPs) and the other side containing [Eu(BA) phen+Tb(BA) phen] (BA = benzoic acid, phen = 1,10-phenanthroline) by parallel electrospinning, resulting in high luminescence intensity almost unaffected by Fe3 O4 MNPs. In addition to using magnetic or fluorescent materials to enhance targeting efficiency, the regulation of morphology, size, and surface composition of carriers affects the therapeutic effect of Drug delivery systems (DDSs) [13]

  • Of a new bionic idea structure rapeseedresults pods demonstrated a distinguished effect with the magnetic–luminescent bifunctional and the core–shell structure of rapeseeds containing oil wrapped in rapeseed pods was rapeseed pod-like for sequential release ofofdual drugs

  • Drug delivery systems (DDSs) with proposed, allowingDDSs the successful establishment magnetic–luminescent excellent magnetic and luminescent properties are highly promising for application in rapeseed pod-like drug delivery carriers (DDCs) for sequential release of dual drugs via double-needle electrospray3+

Read more

Summary

Introduction

MNPs and the other side containing [Eu(BA) phen+Tb(BA) phen] (BA = benzoic acid, phen = 1,10-phenanthroline) by parallel electrospinning, resulting in high luminescence intensity almost unaffected by Fe3 O4 MNPs. In addition to using magnetic or fluorescent materials to enhance targeting efficiency, the regulation of morphology, size, and surface composition of carriers affects the therapeutic effect of DDSs [13]. One chamber contained luminescent NaYF4:Eu3+ NPs and CS NPs, whereas magnetic Fe3O4 MNPs were loaded in another chamber of the DDCs. The dual-chamber structure was expected to reduce the interaction with luminescent material and, enhance luminescent intensity. The sustained release drugs in rapeseed pod-like DDSs showed great utility in continuously inhibiting tumor of drugs in cell growth. Pod-like R2 DDSs for the sequential release of dual drugs

Materials
Synthesis of Fe3 O4 MNPs
Preparation of CS NPs
Preparation of Rapeseed Pod-Like DDCs
Preparation of Rapeseed Pod-Like DDSs
Characterizations
Hemocompatibility Evaluation
In Vitro Release Studies of Two Model Drugs
Cell Culture
Cytotoxicity
Cell Imaging Capability Assay
Drug Release for Killing A549 Cells
Preparation of NPs
O4 MNPs
Physicochemical
Physicochemical Characterizations
Evaluation
MNPs and concentrations
Drug Release Evaluation
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.